51
|
Morrissey J. Fuzzy math. Software vendors' contingency agreements source of questionable accounting practice. MODERN HEALTHCARE 2000; 30:14-5. [PMID: 11155250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
52
|
Morrissey J. N.J. pushes e-claims. By November 2001 all payers will have to do business with providers electronically. MODERN HEALTHCARE 2000; 30:28-9. [PMID: 11143070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
53
|
Warn PA, Morrissey J, Moore CB, Denning DW. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Antimicrob Agents Chemother 2000; 44:2664-71. [PMID: 10991841 PMCID: PMC90132 DOI: 10.1128/aac.44.10.2664-2671.2000] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We compared four doses of amphotericin B lipid complex (ABLC) with three doses of fluconazole in temporarily neutropenic mice in a murine model of disseminated candidiasis due to four different isolates of Candida tropicalis. The mice were infected with a 90% lethal dose of four strains of C. tropicalis for which the fluconazole MICs ranged from 1 to >125 mg/liter 3 days after receiving 200 mg of cyclophosphamide/kg of body weight. Treatment was started 18 h after infection and lasted for 7 days. ABLC (1, 2, 5, and 10 mg/kg) was administered once a day intravenously, fluconazole was administered by oral gavage once daily (25 and 50 mg/kg/day) or twice daily (125 mg/kg). MICs determined in five different ways with 24- and 48-h endpoints were also compared. The overall survival rates were controls, 14%; fluconazole, 64%; and ABLC, 82%. Treatment with ABLC at 2 to 10 mg/kg increased survival compared to controls (P = <0.0001) and was also superior to fluconazole at 25 and 50 mg/kg (P = 0.006). In the fluconazole-resistant C. tropicalis model (MIC, 128 microg/ml), ABLC at 2 to 10 mg/kg was superior to fluconazole at 250 mg/kg and ABLC at 10 mg/kg was superior to all fluconazole doses (P = <0.05). Fluconazole at 250 mg/kg daily was superior to both 25 and 50 mg/kg at reducing mortality with most isolates. ABLC was superior to fluconazole (P = <0.01), and fluconazole at 250 mg/kg was superior to fluconazole at both 25 and 50 mg/kg (P = 0.02) in all models at reducing C. tropicalis counts in the kidneys. Neither drug consistently sterilized the brain or kidneys. A 48-h endpoint reading with the NCCLS susceptibility testing microtiter variation overestimates resistance to fluconazole. ABLC is an effective treatment for fluconazole-resistant C. tropicalis at all doses tested.
Collapse
|
54
|
Morrissey J. Information technology gets priority. MODERN HEALTHCARE 2000; 30:52, 54. [PMID: 11185167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
|
55
|
Morrissey J. Maximizing unused power. Hospitals save millions by extracting more out of information systems already in place. MODERN HEALTHCARE 2000; 30:50-2, 54, 56. [PMID: 11185166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Forced to cut costs, healthcare organizations are taking a pass on the whiz-bang features and elaborate functions of new technology in favor of what's already there. With a new focus on getting more value out of existing technology, providers have discovered unused power in their information systems and are saving millions along the way.
Collapse
|
56
|
Morrissey J. Some advice: standardize systems. MODERN HEALTHCARE 2000; 30:56, 58. [PMID: 11185168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
|
57
|
Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 2000; 279:F130-43. [PMID: 10894795 DOI: 10.1152/ajprenal.2000.279.1.f130] [Citation(s) in RCA: 183] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Unilateral ureteral obstruction (UUO) is a model of renal injury characterized by progressive tubulointerstitial fibrosis and renal damage, while relatively sparing the glomerulus and not producing hypertension or abnormalities in lipid metabolism. Tubulointerstitial fibrosis is a major component of several kidney diseases associated with the progression to end-stage renal failure. Here we report that when a critical renal developmental morphogen, osteogenic protein-1 (OP-1; 100 or 300 microg/kg body wt), is administered at the time of UUO and every other day thereafter, interstitial inflammation and fibrogenesis are prevented, leading to preservation of renal function during the first 5 days after obstruction. Compared with angiotensin-converting enzyme inhibition with enalapril treatment, OP-1 was more effective in preventing tubulointerstitial fibrosis and in preserving renal function. The mechanism of OP-1- induced renal protection was associated with prevention of tubular atrophy, an effect not shared with enalapril, and was related to preservation of tubular epithelial integrity. OP-1 blocked the stimulation of epithelial cell apoptosis produced by UUO, which promoted maintenance of tubular epithelial integrity. OP-1 preserved renal blood flow (RBF) during UUO, but enalapril also stimulated RBF. Thus OP-1 treatment inhibited tubular epithelial disruption stimulated by the renal injury of UUO, preventing tubular atrophy and diminishing the activation of tubulointerstitial inflammation and fibrosis and preserving renal function.
Collapse
|
58
|
Morrissey J. Gemini rising. As powerful computer engine cranks up, medical center can offer more efficient, integrated care. MODERN HEALTHCARE 2000; 30:46, 48-9. [PMID: 11183525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
|
59
|
Swicord M, Morrissey J, Zakharia D, Ballen M, Balzano Q. Dosimetry in mice exposed to 1.6 GHz microwaves in a carrousel irradiator. Bioelectromagnetics 2000; 20:42-7. [PMID: 9915592 DOI: 10.1002/(sici)1521-186x(1999)20:1<42::aid-bem6>3.0.co;2-t] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
We have developed a carrousel irradiator for mice which delivers a head-first and near-field radiofrequency exposure that more closely simulates cellular telephone and radio use than conventional whole body exposure systems. Mouse cadavers were placed on the carrousel irradiator and exposed with their noses 5 mm from the feedpoint of a 1.6 GHz antenna. Local measured specific absorption rates (SAR) in brain regions corresponding to the frontal cortex, medial caudate putamen, and midhippocampal areas were 2.9, 2.4, and 2.2 W/kg per watt of irradiated power, respectively. In addition, average SAR was estimated to be 3.4 W/kg per watt along the sagittal plane of the brain, 2.0 W/kg per watt along the sagittal plane of the body, and between 6.8 and 8.1 W/kg per watt at peak locations along the sagittal plane at the body surface. This detailed SAR information in mice is critical to the interpretation of biological studies of IRIDIUM exposure, and similar analysis should be included for all studies of in vivo exposure of small animals to microwaves.
Collapse
|
60
|
Morrissey J. ASPs (application service providers) can be cure for cash crisis. MODERN HEALTHCARE 2000; Suppl:18-21. [PMID: 11067115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
61
|
Morrissey J. The evolution of a CHIN (community health information network). MODERN HEALTHCARE 2000; Suppl:42-3. [PMID: 11067123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
62
|
Morrissey J. Doctors tap into vital data. MODERN HEALTHCARE 2000; Suppl:44, 46. [PMID: 11067124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
63
|
Morrissey J. Retooled venture resolves claims. MODERN HEALTHCARE 2000; Suppl:38-9, 46. [PMID: 11067122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
64
|
Modun B, Morrissey J, Williams P. The staphylococcal transferrin receptor: a glycolytic enzyme with novel functions. Trends Microbiol 2000; 8:231-7. [PMID: 10785640 DOI: 10.1016/s0966-842x(00)01728-5] [Citation(s) in RCA: 67] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
To obtain iron from the host for growth, staphylococci have evolved sophisticated iron-scavenging systems including siderophores and a cell surface receptor for transferrin, the mammalian iron-transporting glycoprotein. The staphylococcal transferrin receptor has been identified as a member of a newly emerging family of multifunctional, cell-surface-associated glyceraldehyde-3-phosphate dehydrogenases, which not only retain their glycolytic enzyme activities but also bind diverse human serum proteins and possess NAD-ribosylating activity. These multiple functions suggest a potential contribution to virulence far beyond iron acquisition.
Collapse
|
65
|
Morrissey J. McKesson HBOC reorganizes IT unit. MODERN HEALTHCARE 2000; 30:26. [PMID: 11066417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
66
|
Morrissey J. Internet dominates providers' line of sight. MODERN HEALTHCARE 2000; 30:72, 74-8, 80-2 passim. [PMID: 11066427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
67
|
Morrissey J. Solutions in the mist. MODERN HEALTHCARE 2000; 30:102, 104, 106. [PMID: 11066411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
68
|
Morrissey J. Providers put faith in Internet. MODERN HEALTHCARE 2000; 30:64, 66. [PMID: 11010522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
|
69
|
Morrissey J. The great consolidator. Healtheon/WebMD keeps on buying in its bid to dominate online health information. MODERN HEALTHCARE 2000; 30:30-1. [PMID: 11010038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
|
70
|
Kirchheimer B, Bellandi D, Moore JD, Morrissey J, Jaklevic MC, Taylor M, Saphir A, Hensley S, Shinkman R, Hallam K. Outlook 2000. Industry turbulence may subside as Medicare pays more and merged systems look inward.... MODERN HEALTHCARE 2000; 30:25-7, 30-1, 34-6. [PMID: 11009960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
|
71
|
Morrissey J. Top 100 hospitals. MODERN HEALTHCARE 1999; 29:20-4, 28-9. [PMID: 12140822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Abstract
What sets high-performing hospitals apart from the rest of the pack? Despite dwindling Medicare revenues, they manage to get by on whatever they can get. The facilities that performed best clinically and operationally are also far more profitable than the industry at large, and they're doing it despite a sicker patient census than the national norm. Those are among the findings in our report on the top 100 hospitals.
Collapse
|
72
|
Morrissey J. IS staffs try to maximize what they've got. MODERN HEALTHCARE 1999; 29:62. [PMID: 10662209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
|
73
|
Morrissey J. McKesson acquires software developer. MODERN HEALTHCARE 1999; 29:21. [PMID: 10662175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
|
74
|
Morrissey J. Database sharpens performance picture. MODERN HEALTHCARE 1999; 29:46. [PMID: 10623256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
|
75
|
Guo G, Morrissey J, McCracken R, Tolley T, Klahr S. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. THE AMERICAN JOURNAL OF PHYSIOLOGY 1999; 277:F766-72. [PMID: 10564241 DOI: 10.1152/ajprenal.1999.277.5.f766] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Unilateral ureteral obstruction (UUO) results in tubulointerstitial fibrosis of the obstructed kidney. In this study, we report the contribution of tumor necrosis factor-alpha (TNF-alpha) to the fibrosis that develops after ureteral obstruction. Mice in which individual TNF-alpha receptors TNFR1 or TNFR2 had been genetically knocked out were used, and results were compared with mice of C57Bl/6 background after 5 days UUO. Both kidneys were removed and examined histologically for changes in interstitial volume (Vv(int)), collagen IV deposition, alpha-smooth muscle actin (alpha-SMA) matrix score, nuclear factor-kappaB (NF-kappaB) activity, and TNF-alpha mRNA levels. We found that the Vv(int) of contralateral unobstructed kidneys averaged approximately 7% and was indistinguishable among the three genotypes of mice. Vv(int) of ureteral obstructed kidney of C57Bl/6 mice averaged 33 +/- 3.9% after 5 days of UUO. Vv(int) of obstructed kidneys of TNFR1 mice was significantly reduced to 19.4 +/- 3.1%, whereas that of TNFR2 mice was significantly decreased to 25.4% +/- 4.8%. There was a modest but significant difference between Vv(int) of TNFR1 and TNFR2 (P < 0. 047). Both collagen IV and alpha-SMA matrix scores were decreased significantly in obstructed kidney of TNFR1 mouse compared with that of C57Bl/6 and TNFR2 mice. Nuclear extracts prepared from kidney cortex were found to have a significant increase in NF-kappaB binding activity in obstructed kidney compared with contralateral kidney. Individual knockout of the TNFR1 or TNFR2 genes resulted in significantly less NF-kappaB activation compared with the wild type, with TNFR1 being less than TNFR2 knockout. There was a significant increase in TNF-alpha mRNA in the kidney with ureteral obstruction in all three genotypes. TNFR1 knockout displayed a significant reduction in amount of TNF-alpha mRNA induced compared with wild-type or TNFR2 knockout mice. Treatment of TNFR1 knockout mice with an angiotensin converting enzyme inhibitor further decreased Vv(int) and TNF-alpha mRNA induction, suggesting an interaction of ANG II and TNF-alpha systems. These results suggest that TNF-alpha contributes, in part, to changes in interstitial volume, myofibroblast differentiation, and NF-kappaB activation in the kidney during ureteral obstruction. These changes appear to be mediated through both TNFR1 and TNFR2 gene products with effects through the TNFR1 receptor predominating. Furthermore, ANG II appears to stimulate TNF-alpha pathophysiological events leading to renal fibrosis.
Collapse
MESH Headings
- Actins/metabolism
- Angiotensin II/physiology
- Animals
- Antigens, CD/genetics
- Antigens, CD/physiology
- Collagen/metabolism
- Fibrosis
- Immunohistochemistry
- Kidney/metabolism
- Kidney/pathology
- Kidney Tubules/pathology
- Mice
- Mice, Inbred C57BL
- Mice, Knockout/genetics
- Muscle, Smooth/metabolism
- NF-kappa B/metabolism
- RNA, Messenger/metabolism
- Receptors, Tumor Necrosis Factor/genetics
- Receptors, Tumor Necrosis Factor/physiology
- Receptors, Tumor Necrosis Factor, Type I
- Receptors, Tumor Necrosis Factor, Type II
- Tumor Necrosis Factor-alpha/genetics
- Ureteral Obstruction/metabolism
- Ureteral Obstruction/pathology
- Ureteral Obstruction/physiopathology
Collapse
|